Elan is making another bullish Alpha candle today.Stop loss is around 11.20-11.60 range. Target could be 14.60
This gives 1:2 risk/reward ratio. Bullish
Next report date
Report period
Q1 2024
EPS estimate
0.24EUR
Revenue estimate
1.09 BEUR
−2.264EUR
−1.12 BEUR
4.00 BEUR
489.28 M
About Elanco Animal Health Incorporated
Sector
Industry
CEO
Jeffrey N. Simmons
Website
Headquarters
Greenfield
Employees (FY)
9.8 K
Founded
1954
FIGI
BBG00MH8HL37
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Bearish AlertThe hourly chart sees a bearish alert with Bearish Crossover.
The first in a while.
Price Action looks interesting with a trible bottom at 11.46
ELAN reverse to mean tradeDespite negative analyst reviews, ELAN managed to beat EPS and Revenue expectations and prove again that it will fight for market share.
Demand in the stock picked up for the last 2 weeks and a return of the stock price to its 200ma has a high probability to happen.
Do your homework and watch your r
Stocks To WatchThe Market may have some more room to the downside with the longer term uptrend still intact,The Mega Cap stocks have earnings this week. Be careful. These names have shown good relative strength and accumulation volume and most are in the growth sector. This may give good risk/reward entries on som
Elanco (ELAN) Short Setup Idea with Profit TargetsElanco is looking interesting for a short if it doesn't close above this range. Not financial advice.
$ELAN can rise in the next daysContextual immersion trading strategy idea.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for companion and food animals.
The share price rose after the Hedge fund Sachem Head Capital Management has built a $1.2 billion stake i
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange ELANCO ANIMAL HEALTH INC. stocks are traded under the ticker 5EA.
ELANCO ANIMAL HEALTH INC. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
5EA earnings for the last quarter are 0.17 EUR per share, whereas the estimation was 0.12 EUR resulting in a 44.43% surprise. The estimated earnings for the next quarter are 0.09 EUR per share. See more details about ELANCO ANIMAL HEALTH INC. earnings.
ELANCO ANIMAL HEALTH INC. revenue for the last quarter amounts to 1.01 B EUR despite the estimated figure of 983.44 M EUR. In the next quarter revenue is expected to reach 907.49 M EUR.
Yes, you can track ELANCO ANIMAL HEALTH INC. financials in yearly and quarterly reports right on TradingView.
5EA net income for the last quarter is −127.75 M EUR, while the quarter before that showed −1.04 B EUR of net income which accounts for 87.68% change. Track more ELANCO ANIMAL HEALTH INC. financial stats to get the full picture.
No, 5EA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 5EA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELANCO ANIMAL HEALTH INC. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 9.80 K employees. See our rating of the largest employees — is ELANCO ANIMAL HEALTH INC. on this list?
We've gathered analysts' opinions on ELANCO ANIMAL HEALTH INC. future price: according to them, 5EA price has a max estimate of 18.42 EUR and a min estimate of 12.90 EUR. Read a more detailed ELANCO ANIMAL HEALTH INC. forecast: see what analysts think of ELANCO ANIMAL HEALTH INC. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ELANCO ANIMAL HEALTH INC. EBITDA is 924.13 M EUR, and current EBITDA margin is 23.09%. See more stats in ELANCO ANIMAL HEALTH INC. financial statements.